Paper28673296
Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
Hartmann-Johnsen OJ and 3 others. World J Surg Oncol, 2017. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009. Papers, record 28673296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28673296
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Mastectomy | Major topic |
| Mastectomy, Segmental | Major topic |
| Registries | Major topic |
| Aged | |
| Axilla | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Prognosis | |
| Survival Rate |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22373563 | Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. | Lancet Oncol | 2012 | https://conductscience.org/library/papers/22373563 | PubMed |
| 2 | 22113254 | Twenty-five year results of the national cancer institute randomized breast conservation trial. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22113254 | PubMed |
| 3 | 27306422 | The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases. | Breast Cancer Res Treat | 2016 | https://conductscience.org/library/papers/27306422 | PubMed |
| 4 | 24429935 | Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. | JAMA Surg | 2014 | https://conductscience.org/library/papers/24429935 | PubMed |
| 5 | 19114703 | Can women with early-stage breast cancer make an informed decision for mastectomy? | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19114703 | PubMed |
| 6 | 16360786 | Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. | Lancet | 2005 | https://conductscience.org/library/papers/16360786 | PubMed |
| 7 | 23359049 | Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. | Cancer | 2013 | https://conductscience.org/library/papers/23359049 | PubMed |
| 8 | 15161695 | Cellular immunity in breast cancer patients completing taxane treatment. | Clin Cancer Res | 2004 | https://conductscience.org/library/papers/15161695 | PubMed |
| 9 | 25076293 | Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program. | Arch Pathol Lab Med | 2014 | https://conductscience.org/library/papers/25076293 | PubMed |
| 10 | 26517676 | Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis. | Oncotarget | 2015 | https://conductscience.org/library/papers/26517676 | PubMed |
| 11 | 21559024 | Why do hospital mastectomy rates vary? Differences in the decision-making experiences of women with breast cancer. | Br J Cancer | 2011 | https://conductscience.org/library/papers/21559024 | PubMed |
| 12 | 22523340 | The prognostic significance of early stage lymph node positivity in operable invasive breast carcinoma: number or stage. | J Clin Pathol | 2012 | https://conductscience.org/library/papers/22523340 | PubMed |
| 13 | 25315501 | Small breast cancers: when and how to treat. | Cancer Treat Rev | 2014 | https://conductscience.org/library/papers/25315501 | PubMed |
| 14 | 2804892 | The influence of surgical trauma on experimental metastasis. | Cancer | 1989 | https://conductscience.org/library/papers/2804892 | PubMed |
| 15 | 22644510 | Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ. | Ann Surg Oncol | 2012 | https://conductscience.org/library/papers/22644510 | PubMed |
| 16 | 9472641 | Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9472641 | PubMed |
| 17 | 12393820 | Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. | N Engl J Med | 2002 | https://conductscience.org/library/papers/12393820 | PubMed |
| 18 | 23265570 | Prognostic significance of the number of positive lymph nodes in women with T1-2N1 breast cancer treated with mastectomy: should patients with 1, 2, and 3 positive lymph nodes be grouped together? | Int J Radiat Oncol Biol Phys | 2013 | https://conductscience.org/library/papers/23265570 | PubMed |
| 19 | 11745450 | Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT. | Int J Cancer | 2001 | https://conductscience.org/library/papers/11745450 | PubMed |
| 20 | 21646474 | Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors. | Cancer Res | 2011 | https://conductscience.org/library/papers/21646474 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40103401 | Survival after standard or oncoplastic breast-conserving surgery versus mastectomy for breast cancer. | BJS Open | 2025 | https://conductscience.org/library/papers/40103401 | PubMed |
| 39328281 | Higher 10-Year Survival with Breast-Conserving Therapy over Mastectomy for Women with Early-Stage (I-II) Breast Cancer: Analysis of the CDC Patterns of Care Data Base. | Breast Cancer (Auckl) | 2024 | https://conductscience.org/library/papers/39328281 | PubMed |
| 38758563 | Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis. | BJS Open | 2024 | https://conductscience.org/library/papers/38758563 | PubMed |
| 38717543 | "Peace of Mind" After Mastectomy: A Scoping Review. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/38717543 | PubMed |
| 37600290 | Breast-Conserving Surgery or Mastectomy?: Impact on Survival. | Ann Surg Open | 2022 | https://conductscience.org/library/papers/37600290 | PubMed |
| 37358683 | Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients. | Ann Surg Oncol | 2023 | https://conductscience.org/library/papers/37358683 | PubMed |
| 37200923 | The unifying concepts of the sick lobe hypothesis, field cancerisation and breast conservation treatment for multiple ipsilateral breast cancers: a narrative review. | Gland Surg | 2023 | https://conductscience.org/library/papers/37200923 | PubMed |
| 37052762 | Racial/ethnic and socioeconomic differences in breast cancer surgery performed and delayed treatment: mediating impact on mortality. | Breast Cancer Res Treat | 2023 | https://conductscience.org/library/papers/37052762 | PubMed |
| 36618070 | Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy. | J Oncol | 2022 | https://conductscience.org/library/papers/36618070 | PubMed |
| 35459407 | Effect of Local Versus General Anesthesia in Breast-Conserving Surgery on Cancer Recurrence and Cost. | Cancer Control | 2022 | https://conductscience.org/library/papers/35459407 | PubMed |
| 35212160 | Breast-conserving therapy is associated with better survival than mastectomy in Early-stage breast cancer: A propensity score analysis. | Cancer Med | 2022 | https://conductscience.org/library/papers/35212160 | PubMed |
| 34677259 | Multifocality and Multicentrality in Breast Cancer: Comparison of the Efficiency of Mammography, Contrast-Enhanced Spectral Mammography, and Magnetic Resonance Imaging in a Group of Patients with Primarily Operable Breast Cancer. | Curr Oncol | 2021 | https://conductscience.org/library/papers/34677259 | PubMed |
| 34439197 | Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34439197 | PubMed |
| 33049657 | Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study. | Breast | 2020 | https://conductscience.org/library/papers/33049657 | PubMed |
| 32181017 | Saving the Breast Saves the Lives of Breast Cancer Patients. | Int J Surg Oncol | 2020 | https://conductscience.org/library/papers/32181017 | PubMed |
| 31632048 | Investigation of Prognostic Factors of Survival in Breast Cancer Using a Frailty Model: A Multicenter Study. | Breast Cancer (Auckl) | 2019 | https://conductscience.org/library/papers/31632048 | PubMed |
| 31372049 | Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31372049 | PubMed |
| 29218614 | 18F-fluorodeoxyglucose specimen-positron emission mammography delineates tumour extension in breast-conserving surgery: Preliminary results. | Eur Radiol | 2018 | https://conductscience.org/library/papers/29218614 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| NR4A1 | 3164 | PubTator's text mining | https://conductscience.org/library/genes/3164 | NCBI Gene |
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28673296
GET https://conductscience.org/api/papers/v1/28673296/references?page=2